ESR1 and breast cancer: Breast cancer receptor status, most commonly defined by estrogen-receptor (ER), progesterone-receptor (PR), and human epidermal growth factor receptor 2 (HER2) status in the clinical setting, has major implications for breast cancer prevention strategies and patient management [1,2].